weather icon Clear

Vaccines will help fight coronavirus

Many community members may remember standing in long lines at their elementary school, local armory or high school gymnasium in the early 1960s to receive the Sabin oral polio vaccine, drinking a red liquid from a tiny paper cup, that immunized millions, helped to eradicate polio, and is included on the World Health Organization’s List of Essential Medicines.

In the past weeks, two vaccines are being distributed that have been developed to protect individuals from contracting the coronavirus disease 2019. With the death toll in the U.S. over 306,000, and the pandemic showing no signs of slowing, the first vaccine rolled out for frontline health care workers in New York.

Hospitals across the country are set to receive and begin vaccination programs this month.

The first vaccine, manufactured by Pfizer, a 171-year-old Fortune 500 pharmaceutical giant, requires extremely low temperature storage with the vials requiring storage in dry ice-cooled packages as they are transported along with GPS-enabled thermal sensors to track the temperature of shipments.

The second COVID-19 vaccine to receive emergency FDA approval was created by Moderna, a 10-year-old young rival biotech company based in Cambridge, Massachusetts. Both vaccines rely on synthetic messenger RNA, a variation on the natural substance that directs cells to produce proteins.

Where traditional vaccines typically inject a dead or weakened virus into the body to stimulate an immune response, mRNA vaccines are based on custom-made messenger molecules that tell cells to create a viral protein. Both Pfizer and Moderna vaccines instruct cells to create the distinctive spike protein on the coronavirus so that the body’s immune system generates antibodies to fight off the disease.

What is mRNA?

Messenger Ribonucleic Acid (mRNA) molecules that carry the genetic information needed to make proteins, carry the information from the DNA in the nucleus of the cell to the cytoplasm where the proteins are made.

In an ironic twist of pandemics and vaccines, mRNA was actually discovered in the summer of 1961 — the same year that saw the beginnings of the mass distribution of the Sabin oral polio vaccine — by a group of nearly a dozen individual biologists, biochemists, geneticists, zoologists and research scientists — stewards of molecular biology also responsible for cracking the genetic code and arguing for its role in gene regulation.

Nearly 60 years after its discovery, mRNA, the protein-making process harnessed by scientists, is set to help protect us from disease, including COVID-19.

To Your Health is provided by the staff of Boulder City Hospital. For more information, call 702-293-4111, ext. 576, or visit bouldercityhospital.org.

Don't miss the big stories. Like us on Facebook.
Lee: City to get $14 million from rescue plan

Rep. Susie Lee visited Boulder City on Tuesday, April 6, to tout how the American Rescue Plan will benefit the community, small businesses, local residents and the city government, which will receive $14 million directly.

Jorgensen takes top spot in council race

Sherri Jorgensen appears to have been elected to the City Council during Tuesday’s primary election, while Cokie Booth and Matt Fox will likely face off in the June 15 General Election for the second seat.

City attorney finalists interviewed

The city is down to three finalists for a new city attorney and the council could make a decision about who to hire at a special meeting Wednesday, April 14.

Man faces jail time for hoarding cats

A man is facing a misdemeanor charge and possible jail time for hoarding almost 70 cats in his Boulder City mobile home in 2019.

Agency sends grant request for more review

Boulder City’s Redevelopment Agency is holding off on awarding a historic preservation grant to local father and son builders Grant and Larry Turner because it is unsure if the project fits the guidelines for the program.

City backs monument designation

Boulder City is backing a proposed national monument in a part of the Mojave Desert that borders the town.

Early voting underway

Early voting in the primary election to narrow the field of candidates for two open City Council seats began March 25. As of the end of day Tuesday, the most recent numbers available by deadline, 824 voters had cast their ballots.

Interviews set for attorney, manager jobs

The public will have an opportunity in the next two weeks to hear from top applicants for the open city attorney and city manager positions through a series of special City Council meetings.

BCHS, Garrett welcome students to campus

Older students in Boulder City were present in person and on campus Monday, March 22, for the first time in more than a year.

Field narrowed for attorney, manager posts

City Council has narrowed the field of candidates for a new city attorney and city manager and is planning to conduct the first round of interviews the week of April 5.